601607.SS
601607.SS
CNE000000C82
SHANGHAI PHARMACEUTICALS HOLDIN
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
61.86B EUR
57.11B EUR
63.23B EUR
66.23B EUR
Enterprise Value
89.21B EUR
73.52B EUR
85.61B EUR
85.8B EUR
Valuation Multiples
Trailing P/E
12.73x
13.99x
12.35x
13.15x
Forward P/E
10.21x
--
--
--
Price to Sales
0.21x
0.26x
0.29x
0.32x
Price to Book
0.79x
0.73x
0.82x
0.87x
EV/Revenue
0.31x
0.34x
0.4x
0.41x
EV/EBITDA
8.15x
6.67x
6.66x
8.63x
Price to FCF (P/FCF)
48.62x
8.79x
15.08x
22.41x
EV/FCF
70.12x
11.31x
20.42x
29.03x
FCF Yield
2.06%
11.38%
6.63%
4.46%
ende